An investigational trial of VIEKIRA with or without ribavirin in pediatric patients with chronic HCV infection

Trial Profile

An investigational trial of VIEKIRA with or without ribavirin in pediatric patients with chronic HCV infection

Planning
Phase of Trial: Phase II

Latest Information Update: 30 Jul 2015

At a glance

  • Drugs Ombitasvir/paritaprevir/ritonavir (Primary) ; Ribavirin
  • Indications Hepatitis C
  • Focus Adverse reactions; Therapeutic Use
  • Sponsors AbbVie
  • Most Recent Events

    • 30 Jul 2015 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top